Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Ardent Health (ARDT) EBIT (2023 - 2025)

Ardent Health (ARDT) has 3 years of EBIT data on record, last reported at -$278.1 million in Q3 2025.

  • For Q3 2025, EBIT fell 42.76% year-over-year to -$278.1 million; the TTM value through Sep 2025 reached $63.7 million, up 112.02%, while the annual FY2024 figure was -$133.2 million, 55.63% up from the prior year.
  • EBIT reached -$278.1 million in Q3 2025 per ARDT's latest filing, down from -$41.7 million in the prior quarter.
  • Across five years, EBIT topped out at $440.1 million in Q4 2024 and bottomed at -$278.1 million in Q3 2025.
  • Average EBIT over 3 years is -$42.2 million, with a median of -$56.6 million recorded in 2025.
  • The widest YoY moves for EBIT: up 536.2% in 2024, down 138.3% in 2024.
  • A 3-year view of EBIT shows it stood at -$100.9 million in 2023, then soared by 536.2% to $440.1 million in 2024, then tumbled by 163.19% to -$278.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBIT were -$278.1 million in Q3 2025, -$41.7 million in Q2 2025, and -$56.6 million in Q1 2025.